Shanon J. Carson
Shanon J. Carson is a Executive Shareholder of the Firm. He Co-Chairs the Employment & Unpaid Wages, Consumer Protection, Defective Products, and Defective Drugs and Medical Devices Departments and is a member of the Firm’s Commercial Litigation, Employee Benefits & ERISA, Environment & Public Health, Insurance Fraud, Predatory Lending and Borrowers’ Rights, and Technology, Privacy & Data Breach Departments.
Natalie Lesser is Senior Counsel in the Firm’s Consumer Protection and Employee Benefits & ERISA practice groups. She concentrates her practice on automotive defect, consumer fraud, and ERISA class actions.
Phyllis Maza Parker
Phyllis Maza Parker is a Shareholder at the Firm. She is a member of the Firm’s Securities and Investor Protection and Employment Law Departments.
Alexandra K. Piazza
Alexandra Koropey Piazza, Senior Counsel, is a member of the Firm’s Employment Law, Consumer Protection and Lending Practices & Borrowers’ Rights practice groups. In the Employment Law practice group, Ms. Piazza primarily focuses on wage and hour class and collective actions arising under state and federal law.
Camille Fundora Rodriguez
Ms. Rodriguez is a Shareholder in the Firm’s Employment Law, Consumer Protection, and Lending Practices & Borrowers’ Rights practice groups. Ms. Rodriguez primarily focuses on wage and hour class and collective actions arising under the Fair Labor Standards Act and state laws.
Stacy Savett is an attorney in the Firm’s Employment & Unpaid Wages Group. She focuses on wage and hour class and collective actions arising under federal and state laws.
Reginald L. Streater
Reginald L. Streater, an Associate, is a member of the Firm’s Employment & Unpaid Wages, Consumer Protection, and Predatory Lending and Borrowers’ Rights practice groups.
Michaela L. Wallin
Michaela Wallin is an Associate in the Antitrust and Employment Law practice groups. Ms. Wallin’s work in the Antitrust group involves complex class actions, including those alleging that pharmaceutical manufacturers have wrongfully kept less expensive drugs off the market, in violation of the antitrust laws.